BIO vs LQDA · rev $651.0M vs rev $304.5M
BIO (BIO) versus Liquidia Technologies Inc (LQDA) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Liquidia Technologies Inc (LQDA) is a biotechnology company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported LQDA revenue for 2026-06-30 was $304.5M. Net income was $127.6M. LQDA currently screens at market cap $1.04B.
BIO currently screens at market cap $0. LQDA currently screens at market cap $1.04B.
Not investment advice. Open the BIO and LQDA stock pages for the full models.
Not investment advice.